NEW YORK (GenomeWeb) — OneOme announced today that its RightMed pharmacogenomic test has received approval from the New York State Department of Health (NYSDH).

RightMed covers 27 genes in which variants are known to contribute to the effectiveness or safety of more than 360 medications for 30 conditions. With the NYSDH approval, Minneapolis-based OneOme said it can offer the PCR-based test in all 50 states, in addition to certain international locations.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.